Georgia Healthcare Group PLC Notice of Results (6866G)
08 November 2018 - 6:01PM
UK Regulatory
TIDMGHG
RNS Number : 6866G
Georgia Healthcare Group PLC
08 November 2018
London, 8 November 2018
Georgia Healthcare Group PLC notice of 3Q and 9M 2018
Results
Georgia Healthcare Group PLC ("GHG") will publish its financial
results for 3Q and 9M 2018 at 07:00 London time on Monday, 12
November 2018. The results announcement will be available on GHG's
website at ghg.com.ge. An investor/analyst conference call,
organised by GHG, will be held on Monday, 12 November 2018, at
10:00 UK / 11:00 CET. The duration of the call will be 60 minutes
and will consist of a 15-minute update and a 45-minute Q&A
session.
Dial-in numbers: 30-Day replay
Pass code for replays / conference Pass code for replays / conference
ID: 5776845 ID:5776845
International Dial in: +44 (0) 2071 International Dial in: +44 (0)
928000 3333 00 97 85
UK: 08445718892 UK National Dial in: 08717000471
US: 16315107495 UK Local Dial in: 08445718951
Austria: 019286559 US Free Call Dial in: 1 (917) 677
7532
Belgium: 024009874
Czech Republic: 228881424
Finland: 0942450806
France: 0176700794
Germany: 06924437351
Ireland: 014319615
Italy: 0687502026
Netherlands: 0207143545
Norway: 23960264
Spain: 914146280
Sweden: 0850692180
Switzerland: 0315800059
Name of authorised official of issuer responsible for making
notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding
company of the largest healthcare services provider in the
fast-growing, predominantly privately-owned, Georgian healthcare
services market. GHG's leadership position is underpinned by
offering the most comprehensive range of inpatient and outpatient
services targeting the mass market segment through its vertically
integrated network of 37 hospitals and 17 district polyclinics. GHG
is the single largest market participant, accounting for 24.9% of
total hospital bed capacity in the country, as of 30 June 2018. GHG
is also the largest pharmaceuticals retailer and wholesaler in
Georgia, with approximately 30% market share by revenue. GHG is the
second largest provider of medical insurance in Georgia with a
27.2% market share based on net insurance premiums earned and
approximately 157,000 insurance customers as at June 2018. GHG
employed a total of c.15,500 people as at 30 June 2018, including
c.3,600 physicians.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze Irakli Gogia Ketevan Kalandarishvili
CEO CFO Head of Investor
Relations
+995 322 550505
+995 322 550505 (5077) +995 322 550505 (5088) (5079)
ngamkrelidze@ghg.com.ge irakligogia@ghg.com.ge ir@ghg.com.ge
This news report is presented for general informational purposes
only and should not be construed as an offer to sell or the
solicitation of an offer to buy any securities
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORQDLFBVFFFFBZ
(END) Dow Jones Newswires
November 08, 2018 02:01 ET (07:01 GMT)
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Apr 2024 to May 2024
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From May 2023 to May 2024